TB is a top global killer, responsible for nearly 2 million deaths a year
The TB Pandemic
Read more about what we do.
The TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster-acting, and affordable tuberculosis drugs that are available to those who need them.
Our Mission >Today's TB treatment takes too long and drives the spread of resistance
Inadequate TreatmentPromise in the pipeline means new hope in stopping TB
Developing Regimens
TB affects every country in the world. Find out how we are making progress in the fight against tuberculosis.
Our Pipeline
The TB Alliance, along with its partners around the world, is leading the development of the most comprehensive TB drug portfolio in history.
Developing Tomorrow's Cures
Accelerating the Pace
The TB Alliance is not just developing new drugs, but changing the way TB drugs are developed.
Engaging Communities
Affordable, Accessible, Available
The TB Alliance's mission is not complete until new drugs are in the hands of those who need them.
TB Alliance Innovations
Critical Path to TB Drug Regimens
CPTR is a cross-sector initiative that aims to telescope the time needed to develop and make available novel TB and MDR-TB drug regimens.
Frontlines: Voices of TB
Dr. Anthony Fauci
The importance of developing new TB drugs in combination